A randomized, controlled, multicenter trial to evaluate the safety and efficacy of Zotarolimus- vs. Paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries: five-year results from the ZOMAXX I trial
Bernard Chevalier, Carlo Dimario, Franz-Josef Neumann, Donald E Cutlip, David O Williams, John Ormiston, Eberhard Grube, Robert Whitbourn, Jessie Coe, Lewis B Schwartz, ZOMAXX I Investigators, Kari Saunamäki
6
Citations
(Scopus)